Centre Paul Strauss
Clinical trials sponsored by Centre Paul Strauss, explained in plain language.
-
Sharper radiation aimed at deadly brain cancer
Disease control Recruiting nowThis study is testing a refined radiation technique for adults with glioblastoma, a very aggressive brain cancer. It aims to see if using a special PET scan to guide a higher, more focused dose of radiation to the most active tumor areas can help patients live longer. The trial i…
Phase: PHASE2 • Sponsor: Centre Paul Strauss • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Targeted radiation boost aims to fight returning brain cancer
Disease control Recruiting nowThis study is testing a new way to deliver radiation to patients whose aggressive brain cancer (glioblastoma) has returned. It uses a special PET scan to pinpoint the most active parts of the tumor, then aims a higher dose of radiation directly at those spots. The goal is to bett…
Phase: PHASE2 • Sponsor: Centre Paul Strauss • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New program aims to help seniors stick with cancer treatment
Disease control Recruiting nowThis study is testing whether a coordinated care program helps older adults complete their planned digestive cancer chemotherapy. It will enroll 144 participants aged 75 and older who are starting treatment. The goal is to see if early support from a team of specialists helps pat…
Phase: NA • Sponsor: Centre Paul Strauss • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope for Tough-to-Treat head & neck cancers
Disease control Recruiting nowThis study is testing a combination of three drugs (carboplatin, paclitaxel, and cetuximab) for adults with head and neck cancer that has returned or spread after their first treatment with pembrolizumab immunotherapy. The main goal is to see how well this three-drug combo shrink…
Phase: PHASE2 • Sponsor: Centre Paul Strauss • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New scan could reveal hidden details of brain tumors
Diagnosis Recruiting nowThis study is testing a new type of MRI scan, called CEST, to see if it can create better maps of brain tumors. It will be added to standard PET/MRI exams for 800 patients with glioma or brain metastases. The goal is to see if measuring the acidity (pH) inside tumor tissue can he…
Phase: NA • Sponsor: Centre Paul Strauss • Aim: Diagnosis
Last updated Mar 31, 2026 12:11 UTC
-
New scan technology tested for better cervical cancer detection
Diagnosis Recruiting nowThis study is testing whether a newer type of scan (PET/MRI) is better than the current standard scan (PET/CT) at finding if cervical cancer has spread to lymph nodes. Researchers will compare both scans in 50 patients with locally advanced cervical cancer. The goal is to see if …
Sponsor: Centre Paul Strauss • Aim: Diagnosis
Last updated Mar 30, 2026 14:35 UTC
-
Can a weekly bike ride fight chemo fatigue?
Symptom relief Recruiting nowThis study is testing if a weekly cycling exercise program helps breast cancer patients better tolerate chemotherapy. Researchers want to see if patients who cycle during their 15-week treatment maintain better fitness and strength compared to those who receive standard care alon…
Phase: NA • Sponsor: Centre Paul Strauss • Aim: Symptom relief
Last updated Apr 02, 2026 14:57 UTC
-
Horses help kids cope with cancer treatment
Symptom relief Recruiting nowThis study explores whether horse-assisted therapy can help children and teenagers feel less anxious and improve their quality of life while they receive radiotherapy for cancer. Researchers will measure changes in anxiety and well-being in about 22 young patients aged 8 to 18. T…
Phase: NA • Sponsor: Centre Paul Strauss • Aim: Symptom relief
Last updated Mar 23, 2026 15:16 UTC
-
Scientists probe why chemo makes exercise so hard
Knowledge-focused Recruiting nowThis study aims to understand why breast cancer patients often struggle with exercise after chemotherapy. Researchers will compare 24 women who recently finished chemo with 24 healthy women, measuring how their hearts and nerves respond to gentle leg movements and blood pressure …
Phase: NA • Sponsor: Centre Paul Strauss • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:56 UTC
-
Huge study hunts for early warning signs of deadly gallbladder cancer
Knowledge-focused Recruiting nowThis large international research project aims to understand why some people with gallstones develop gallbladder cancer. By studying 15,000 people in Europe and Latin America, researchers will collect health information and samples to identify risk factors and potential early war…
Sponsor: Centre Paul Strauss • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC
-
Scientists hunt for clue to stop chemo from hurting hearts
Knowledge-focused Recruiting nowThis study aims to understand why some breast cancer patients develop heart damage from a common chemotherapy drug called anthracycline. Researchers will test if a specific protein in the blood (SGLT2) can serve as an early warning sign for this heart risk. The goal is to find a …
Sponsor: Centre Paul Strauss • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC